October 12, 2023 – Page 2

Root, Inc. Schedules Conference Call to Discuss Third Quarter 2023 Financial Results

Written by Customer Service on October 12, 2023. Posted in Public Companies.

COLUMBUS, Ohio, Oct. 12, 2023 (GLOBE NEWSWIRE) — Root, Inc. (NASDAQ: ROOT), the parent company of Root Insurance Company, today announced its plans to host a conference call to discuss financial results for the third quarter on Thursday, November 2, 2023 at 8:00 a.m. Eastern Time. The company plans to release third quarter results in the investor relations section of its website at ir.joinroot.com after the close of the financial markets on Wednesday, November 1, 2023. Webcast and Conference Call Details: Date: November 2, 2023Time: 8:00 a.m. Eastern TimeParticipant Toll-Free Dial-In Number: 1 (888) 660-6392Participant Toll Dial-In Number: 1 (929) 203-0899 Conference ID: 3641459Webcast: https://ir.joinroot.com/news-events/events A replay of the webcast will be made available for on-demand viewing after the call on the Investor...

60 Degrees Pharmaceuticals Suspends Phase IIB Study of Tafenoquine for COVID-19, Pivots to Refocus on Commercialization of Treatments for Malaria and Tick-Borne Diseases

Written by Customer Service on October 12, 2023. Posted in Public Companies.

TTCR Improvement Tafenoquine v Placebo Simulated survival curve of sustained 4-day recovery from acute COVID-19 symptoms in the subset of non-hospitalized high and low risk patients enrolled in NCT04533347 with at least two moderate COVID symptoms randomized to receive tafenoquine or placebo (post hoc endpoint). FDA advice to Company suggested execution of ACLR8-LR, a placebo-controlled Phase IIB study of tafenoquine in COVID-19 patients, may not be feasible in the U.S. Company will therefore focus efforts on further commercialization related to ARAKODA® (tafenoquine) for prophylaxis of malaria, and prepare for a Phase IIA study of tafenoquine in hospitalized babesiosis patients Company is preparing for submission of a pre-IND meeting request with FDA for babesiosis in the current fourth quarter of 2023, and plans to appoint...

Oil-Dri Announces Record Financial Results for the Fourth Quarter and Fiscal Year 2023

Written by Customer Service on October 12, 2023. Posted in Earnings Releases And Operating Results.

CHICAGO, Oct. 12, 2023 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its fourth quarter and fiscal year 2023. Fourth Quarter Year to Date (in thousands, except per share amounts) Ended July 31, Ended July 31, 2023 2022 Change 2023 2022 Change Consolidated Results Net Sales $ 107,388 $ 93,158 15% $ 413,021 $ 348,589 18% Net Income Attributable to Oil-Dri $ 11,919 $ 5,196 129% $ 29,551 $ 5,674 421% Net Income Attributable to Oil-Dri Excluding Nonrecurring Events† $ 12,076 $ 5,196 132% $ 36,469 $ 10,136 260% Diluted EPS – Common $ 1.67 $ 0.77 117% $ 4.13 $ 0.81 410% Diluted EPS – Common, Excluding Nonrecurring Events† $ 1.69 $ 0.77 119% $ 5.10 $ 1.46 249% Business to Business Net...

Nurix Therapeutics Reports Third Quarter Fiscal 2023 Financial Results and Provides a Corporate Update

Written by Customer Service on October 12, 2023. Posted in Earnings Releases And Operating Results.

Announced strategic collaboration with Seagen to develop a portfolio of Degrader-Antibody Conjugates, resulting in a $60 million upfront payment Achieved an additional $8 million in research milestones for the quarter, resulting in milestone and license fee payments totaling $35.5 million year-to-date from Gilead and Sanofi Maintained strong financial position with cash runway into the second quarter of 2025 SAN FRANCISCO, Oct. 12, 2023 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with hematologic malignancies and solid tumors, today reported financial results for the fiscal quarter ended August 31, 2023, and provided a corporate update. “As our drug development pipeline continues to advance in the clinic,...

FutureFuel to Release Third Quarter 2023 Financial Results on November 9, 2023

Written by Customer Service on October 12, 2023. Posted in Public Companies.

CLAYTON, Mo., Oct. 12, 2023 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, announced today that it will release its third quarter 2023 financial results after market close on Thursday, November 9, 2023. About FutureFuel FutureFuel is a leading manufacturer of diversified chemical products, specialty chemical products, and biofuel products. In its chemicals business, FutureFuel manufactures specialty chemicals for specific customers (“custom chemicals”) as well as multi-customer specialty chemicals (“performance chemicals”). FutureFuel’s custom chemicals product portfolio includes proprietary intermediates for major chemical companies and chlorinated polyolefin adhesion promoters and antioxidant precursors for a major chemical company. FutureFuel’s...

Founder & CEO, Roger James Hamilton, provides personal funding of up to $4 million in Genius Group

Written by Customer Service on October 12, 2023. Posted in Public Companies.

SINGAPORE, Oct. 12, 2023 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, announces today that it has entered into a loan agreement with its CEO, Roger James Hamilton, to provide the company with up to $4 million as an interest free loan, to be converted into equity in Genius Group as ordinary shares and upon the same terms at the next Qualified Financing Round. CEO of Genius Group, Roger Hamilton, said “I founded this company and am fully committed to our mission and future success. As the company continues on its growth path, and as we continue to sign new partnerships and joint ventures that harness cutting-edge technologies to serve our students, users and partners in unique way, I want to ensure our company continues to grow without...

ALSTOM SA: Moody’s Investors Service confirms Alstom’s Baa3 long-term issuer rating. Credit outlook lowered to negative from stable. Alstom reaffirms its commitment to an Investment Grade rating.

Written by Customer Service on October 12, 2023. Posted in Public Companies.

Moody’s Investors Service confirms Alstom’s Baa3 long-term issuer rating Credit outlook lowered to negative from stable Alstom reaffirms its commitment to an Investment Grade rating 12 October 2023 – The credit rating agency Moody’s Investors Service has on 12 October decided to confirm Alstom’s Baa3 long-term issuer rating. It has lowered its credit outlook to Negative from Stable. The details of the action taken by Moody’s are as follows: Alstom Moody’s rating Outlook Negative (vs Stable) Issuer rating Baa3 (unchanged) Senior Unsecured Baa3 (unchanged) Short-term rating P-3 (unchanged) Source :Moody’s Investors Service. Moody’s methodology: Moody’s is using the Global Manufacturing Companies rating...

Meridian Bank Announces Retirement of Chief Credit Officer Joe Cafarchio

Written by Customer Service on October 12, 2023. Posted in Public Companies.

Chief Credit Officer Joe Cafarchio Chief Credit Officer Joe Cafarchio MALVERN, Pa., Oct. 12, 2023 (GLOBE NEWSWIRE) — Meridian Bank (Nasdaq: MRBK) announced the retirement of Joseph Cafarchio, Chief Credit Officer, effective October 13, 2023. Mr. Cafarchio has served in the position since Meridian’s inception in 2004. Prior to joining Meridian, Joe had a long career in the Philadelphia-area banking community, including positions with National Penn Bank, Stonebridge Bank and the Philadelphia Federal Reserve, where he started his career after graduating from Wharton. Before entering the financial world, he pursued his other professional passion as a saxophonist in a nationally touring band. While at Meridian, Joe often combined these two areas of talent by breaking out his horn to the delight of all at Meridian employee and...

Better Choice Announces Partnership with Aimia Pet Health to Develop a GLP1 Supplement for its Halo Brand to Combat Obesity in Dogs and Cats

Written by Customer Service on October 12, 2023. Posted in Public Companies.

TAMPA, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) — Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced it has signed a research and development partnership with Aimia Pet Health to develop a GLP1 supplement for overweight pets under its Halo brand. More than half of all dogs and cats worldwide are classified as overweight or obese and can suffer from the same weight-related health complications as humans – including arthritis, diabetes, and high blood pressure. Following the successful creation by Pfizer of its Slentrol medication, Better Choice will work with Aimia Pet Health to develop treats and toppers to safely combat pet obesity. The goal of the research and development work is to mirror the weight loss benefits of leading brands for domestic animals and in...

La Rosa Announces Closing of Initial Public Offering

Written by Customer Service on October 12, 2023. Posted in Public Companies.

CELEBRATION, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a holding company for five agent-centric, technology-integrated, cloud-based, multi-service real estate companies, today announced the closing of its underwritten initial public offering of 1,000,000 shares of common stock at an initial public offering price of $5.00 per share. The gross proceeds from the offering, before underwriting discounts and commissions and estimated offering expenses payable by the Company, are expected to be $5,000,000. In addition, the Company has granted the underwriters a 45-day option to purchase up to 150,000 additional shares of common stock at the initial public offering price, less the underwriting discount, to cover over-allotments, if any. The shares began trading on The Nasdaq...

Day: October 12, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice